Enfusion (ENFN)
(Real Time Quote from BATS)
$9.51 USD
+0.09 (0.96%)
Updated Apr 29, 2024 03:04 PM ET
4-Sell of 5 4
F Value A Growth B Momentum B VGM
Price, Consensus and EPS Surprise
ENFN 9.51 +0.09(0.96%)
Will ENFN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ENFN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ENFN
Enfusion, Inc. (ENFN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Enfusion, Inc. (ENFN) Lags Q4 Earnings Estimates
ENFN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Box (BOX) Q4 Earnings Beat Estimates
Strength Seen in Phunware (PHUN): Can Its 75.3% Jump Turn into More Strength?
Arteris, Inc. (AIP) Reports Q4 Loss, Tops Revenue Estimates
Other News for ENFN
Notable Two Hundred Day Moving Average Cross - ENFN
Enfusion Announces Date of First Quarter 2024 Results
Piper Sandler Reaffirms Their Hold Rating on Enfusion (ENFN)
The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024
Bullish Two Hundred Day Moving Average Cross - ENFN